Medium Risk

Shalby Limited

Hospital Activities

CIN: L85110GJ2004PLC044667 FY: 2024-2025 Revenue: ₹872.7 Cr
5.3
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.0
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
5.0
Governance Risk
3.0

Financial Exposure

Est. Compliance Cost₹1–5 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated230.1 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyYes
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.3
Impact Materiality5.1
QuadrantDual Materiality

Supply Chain

MSME Sourcing—%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

**Shalby Limited – Financial Risk Summary** Shalby's primary financial exposure stems from critical compliance gaps, evidenced by a maximum 10.0/10 compliance risk score and estimated remediation costs of ₹1–5 crore, with acute risk of SEBI enforcement action or delisting if BRSR disclosure obligations under Core Expansion framework are not addressed. The company's undefined EPR (Extended Producer Responsibility) exposure (6.5/10 risk) represents a contingent liability risk, particularly if medical waste management obligations are newly classified or enforcement tightens under biomedical waste rules. While Scope 1 and 2 emissions data are absent from reporting, absence of disclosed GHG metrics (despite 5.0/10 intensity risk rating) suggests potential underestimation of scope-based liabilities and future carbon pricing exposure under India's potential domestic carbon credit trading scheme (₹600–900/tonne benchmark). Immediate prioritization of BRSR compliance documentation and quantification of EPR obligations is essential to mitigate regulatory penalties and market valuation risk.

Source: Shalby Limited BRSR Filing, FY 2024-2025. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →